Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Operating Expenses (2021 - 2025)

Historic Operating Expenses for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q3 2025 value amounting to $1.7 million.

  • Cardio Diagnostics Holdings' Operating Expenses rose 2111.59% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 2223.91%. This contributed to the annual value of $8.4 million for FY2024, which is 1572.06% up from last year.
  • Cardio Diagnostics Holdings' Operating Expenses amounted to $1.7 million in Q3 2025, which was up 2111.59% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Operating Expenses registered a high of $4.2 million during Q1 2024, and its lowest value of $397.0 during Q2 2021.
  • For the 5-year period, Cardio Diagnostics Holdings' Operating Expenses averaged around $1.4 million, with its median value being $1.5 million (2023).
  • Per our database at Business Quant, Cardio Diagnostics Holdings' Operating Expenses skyrocketed by 19812770.78% in 2022 and then tumbled by 6091.26% in 2025.
  • Quarter analysis of 5 years shows Cardio Diagnostics Holdings' Operating Expenses stood at $20887.0 in 2021, then soared by 11289.89% to $2.4 million in 2022, then crashed by 34.96% to $1.5 million in 2023, then decreased by 1.71% to $1.5 million in 2024, then grew by 12.73% to $1.7 million in 2025.
  • Its Operating Expenses was $1.7 million in Q3 2025, compared to $1.7 million in Q2 2025 and $1.6 million in Q1 2025.